Behr, T M <br/><br/>
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Jun 1997 
 - 858-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0161-5505 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Anti-Idiotypic--immunology<br/>Antibodies, Monoclonal--adverse effects<br/>Bone Marrow--radiation effects<br/>Carcinoembryonic Antigen--immunology<br/>Female<br/>Humans<br/>Iodine Radioisotopes--adverse effects<br/>Male<br/>Middle Aged<br/>Neoplasms--diagnostic imaging<br/>Radioimmunotherapy--adverse effects<br/>Radiotherapy Dosage<br/>Risk Factors<br/>Tomography, Emission-Computed, Single-Photon